Catherine Wood's LLY Position Overview
Catherine Wood (via Ark Investment Management LLC) currently holds 12,676 shares of Eli Lilly and Company (LLY) worth $11.66 M, representing 0.09% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Catherine Wood has initiated a new position in LLY, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Catherine Wood's Eli Lilly and Company (LLY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eli Lilly and Company (LLY) Trades by Catherine Wood
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +12,676 | New Buy | 12,676 | $919.74 |
Catherine Wood's Eli Lilly and Company Investment FAQs
Catherine Wood first purchased Eli Lilly and Company (LLY) in Q1 2026, acquiring 12,676 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood has held Eli Lilly and Company (LLY) for 1 quarters since Q1 2026.
Catherine Wood's largest addition to Eli Lilly and Company (LLY) was in Q1 2026, adding 12,676 shares worth $11.66 M.
According to the latest 13F filing for Q1 2026, Catherine Wood's firm, Ark Investment Management LLC, owns 12,676 shares of Eli Lilly and Company (LLY), valued at approximately $11.66 M.
As of the Q1 2026 filing, Eli Lilly and Company (LLY) represents approximately 0.09% of Catherine Wood's publicly disclosed stock portfolio, making it one of their key holdings.
Catherine Wood's peak holding in Eli Lilly and Company (LLY) was 12,676 shares, as reported at the end of Q1 2026.